As Government Suspends Operations, Science Projects Go on Hold

Thousands of federal employees go on furlough during the shutdown, which could put a stop to research.

kerry grens
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, O.J.The U.S. government is now in its third day of a shutdown, as Congress has failed to agree upon a spending package. The Senate is scheduled to vote at noon today (January 22) on a bill to keep the lights on for several weeks while negotiations continue. In the meantime, thousands of federal employees at science agencies, among others, are on furlough, creating a ripple effect beyond their own departments.

For instance, science funders, such as the National Institutes of Health (NIH) and the National Science Foundation, will stop processing grants, which could leave recipients in a lurch. Patients seeking to enter clinical trials conducted by the NIH may also be turned away, although those already in an experiment will continue to receive care, Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, told the Associated Press Friday.

Fauci described the state of his department as a “scramble” on Friday, as scientists had to make decisions about the fate of their experiments, not knowing how long the shutdown would last. “You can’t push the pause button on an experiment when you inject an animal with a particular substance to see what the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • kerry grens

    Kerry Grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours